Clinical Terminal
Opinion

Hiteks MD: AI in CDI Creates New Regulatory Risks Beyond Current Guidance

In a June 20, 2026, article published by Hiteks, Gerasimos Petratos, MD, addressed the regulatory implications of integrating artificial intelligence into Clinical Documentation Improvement (CDI) workflows. Petratos asserted that AI technology operates fully within the existing regulatory framework.

By The Desk - Jordan Leahy·June 22, 2026
Hiteks MD: AI in CDI Creates New Regulatory Risks Beyond Current Guidance

He warned that AI in this context can create new risk categories that current regulatory guidance has not yet caught up to, creating a potential liability gap.

Petratos urged the industry to proactively address this gap, noting that organizations that develop solutions for these new risks could gain a market advantage.